An Atogepant Study in Healthy Chinese Participants

Study Identifier
3101-104-002
CT.gov Identifier
Not available
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Not available
Sign up for trial alerts

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Migraine - General
    • Study Drug
    N/A
    Phase
    Phase 1
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria

    Protocol Summary

    To evaluate the safety, tolerability and pharmacokinetics of atogepant administered as a single dose in healthy Chinese participants

    Study Locations

    No locations found.